CLINICAL PHARMACOKINETICS AND PHARMACODYNAMICS OF WARFARIN - UNDERSTANDING THE DOSE-EFFECT RELATIONSHIP

被引：221
|
作者：
HOLFORD, NHG
机构：
来源：
CLINICAL PHARMACOKINETICS | 1986年 / 11卷 / 06期
关键词：
D O I：
10.2165/00003088-198611060-00005
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：483 / 504
页数：22
相关论文
共 50 条
  • [31] Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers
    Van Hecken, A
    Depré, M
    Verbesselt, R
    Wynants, K
    De Lepeleire, I
    Arnout, J
    Wong, PH
    Freeman, A
    Holland, S
    Gertz, B
    De Schepper, PJ
    JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (05): : 495 - 500
  • [32] Effect of Carisbamate on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Participants
    Gonzalez, Martha
    Zannikos, Peter
    DiBernardo, Allitia
    Brashear, H. Robert
    Ariyawansa, Jay
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (09): : 1420 - 1429
  • [33] Effect of nebicapone on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects
    Luis Almeida
    Amílcar Falcão
    Manuel Vaz-da-Silva
    Teresa Nunes
    Ana-Teresa Santos
    José-Francisco Rocha
    Carla Neta
    Tice Macedo
    C. Fontes-Ribeiro
    P. Soares-da-Silva
    European Journal of Clinical Pharmacology, 2008, 64
  • [34] Dose-effect and dose-response relationship
    Bard, Denis
    Cerf, Olivier
    ENVIRONNEMENT RISQUES & SANTE, 2007, 6 (05): : 382 - 382
  • [35] Effect of the oral renin inhibitor aliskiren on the pharmacokinetics and pharmacodynamics of a single dose of warfarin in healthy subjects
    Dieterle, W
    Corynen, S
    Mann, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (04) : 433 - 436
  • [36] The integration of pharmacokinetics and pharmacodynamics: Understanding dose-response
    Abdel-Rahman, SM
    Kauffman, RE
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2004, 44 : 111 - 136
  • [37] Clomipramine dose-effect study in patients with depression: Clinical end points and pharmacokinetics
    Glue, P
    Andersen, KO
    Hansen, MA
    Stage, KB
    Hansen, H
    Norrie, B
    Hansen, PEB
    Knudsen, L
    Thomsen, R
    Pedersen, I
    Jessen, IM
    Haffner, F
    Hansen, JB
    Berthou, E
    Kierkegaard, H
    Andersen, TH
    Bjarking, L
    Bech, P
    Bendsen, BB
    Spanager, S
    LaBianca, J
    Jha, S
    Hoybye, E
    Bysted, M
    Rasmussen, NA
    Moller, AG
    Welter, H
    Justesen, EM
    Merinder, L
    Andersen, F
    Bartels, U
    Borg, L
    Christensen, J
    Weeke, A
    Raben, H
    Larsen, JK
    Knudsen, H
    Jorgensen, O
    Knudsen, AF
    Horsboll, H
    Waago, K
    Christensen, B
    Christensen, NB
    Thiesen, S
    Wernlund, HH
    Thomsen, IS
    Christensen, EM
    Skovgaard, K
    Andersen, J
    Andersen, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (02) : 152 - 165
  • [38] Gaboxadol does not affect the single dose pharmacokinetics of the R(+) and S(-) enantiomers of warfarin and the pharmacodynamics of warfarin
    Ramakrishnan, R.
    Cerchio, K.
    Talaty, J.
    Danjou, P.
    Gargano, C.
    Lasseter, K.
    Murphy, M.
    Alexander, R.
    SLEEP, 2006, 29 : A39 - A39
  • [39] DOSE-EFFECT RELATIONSHIP IN THERAPY WITH PIRACETAM
    KRETSCHMAR, JH
    KRETSCHMAR, C
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1976, 26 (06): : 1158 - 1159
  • [40] Effect of Daridorexant on the Pharmacokinetics of Midazolam, and on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Male Subjects
    Isabelle Zenklusen
    Jasper Dingemanse
    Christian Reh
    Martine Gehin
    Priska Kaufmann
    Drugs in R&D, 2024, 24 : 97 - 108
12345